Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.7B | 9.8B | 11.4B | 10.4B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.3B | 1.5B | 1.3B | 1.4B |
Other operating expenses | 389K | -8.4M | 3.9M | -1.1M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.1B | 4.4B | 4.6B | 4.6B |
Tax provision | 960.3M | 659.7M | 763.1M | 1.0B |
Net income | 4.1B | 3.7B | 3.8B | 3.6B |
Basic EPS | 0.4 | — | 0.3 | 0.3 |
Diluted EPS | 0.4 | — | 0.3 | 0.3 |
Basic average shares | 11.2B | — | 11.2B | 11.7B |
Diluted average shares | 11.3B | — | 11.2B | 11.7B |
EBITDA | — | — | — | — |
Net income from continuing op. | 5.1B | 4.4B | 4.6B | 4.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |